SkepSkep
All episodes
Motley Fool Hidden Gems Investing — Biotech Beat NVIDIA in 2025. Can It Do It Again?
Not scored yet24m·2026-02-02·Money

Biotech Beat NVIDIA in 2025. Can It Do It Again?

Motley Fool Hidden Gems Investing

Big pharma and biotech take the earnings stage this week with reports from Eli Lilly (NYSE: LLNY) and Novo Nordisk (NYSE: NVO) leading the lineup. Will they help the industry once again outperform AI champ NVIDIA (NASDAQ: NVDA), as the industry did in 2025? Karl Thiel, Tom King, and Tim Beyers discuss: - Slow rolling…

Listen in your app
Buzzmeter · cross-platform
Not scored yet

We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.

Hive Vote · Skep listeners
New on SkepAwaiting the hive's first votes

Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.

Rate this episode

Add your vote to the Hive — listeners rate every episode after they finish.

Rate this episode
Recent reviews
  • No reviews yet — be the first.

One great episode in your inbox, daily — free.

One email a day, unsubscribe anytime. No spam, ever.